May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Single Doses of a New Vitamin A Derivative (AG-787-14-1) Selectively Slow Down Rod Visual Cycle in Rats
Author Affiliations & Notes
  • A. Messias
    Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany
  • R. T. Tzekov
    Drug Discovery Division, Acucela Inc., Bothell, Washington
  • D. McGee
    Drug Discovery Division, Acucela Inc., Bothell, Washington
  • T. Peters
    Steinbeis Transfer Centre (STC) for Biomedical Optics and Function Testing, Tuebingen, Germany
  • B. Wilhelm
    Steinbeis Transfer Centre (STC) for Biomedical Optics and Function Testing, Tuebingen, Germany
  • A. Baryluk
    Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany
  • F. Gekeler
    Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany
  • R. Kubota
    Drug Discovery Division, Acucela Inc., Bothell, Washington
  • E. Zrenner
    Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany
  • Footnotes
    Commercial Relationships  A. Messias, None; R.T. Tzekov, Acucela Inc., E; D. McGee, Acucela Inc., E; T. Peters, None; B. Wilhelm, None; A. Baryluk, None; F. Gekeler, None; R. Kubota, Acucela Inc., E; E. Zrenner, None.
  • Footnotes
    Support  Acucela Inc. (additional support: Tistou & Charlotte Kerstan Stiftung)
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 3516. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Messias, R. T. Tzekov, D. McGee, T. Peters, B. Wilhelm, A. Baryluk, F. Gekeler, R. Kubota, E. Zrenner; Single Doses of a New Vitamin A Derivative (AG-787-14-1) Selectively Slow Down Rod Visual Cycle in Rats. Invest. Ophthalmol. Vis. Sci. 2008;49(13):3516. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To quantify the effect and test the reversibility of a single dose of a new vitamin A derivative (AG-787-14-1) on retinal function in rats.

Methods: : A total of 36 Brown Norway rats were assigned either into a control group (vehicle injected) (n=13), or in one of 3 groups treated with single dose intra-peritoneal application of AG-787-14-1 either at 20 (n=8); 5 (n=7) or 1 mg/kg (n=8). Evaluations were performed at baseline and 12 hours after treatment by means of Ganzfeld ERGs. Intensity-response relationship of b-wave amplitude was evaluated at scotopic conditions by applying white stimuli (0.00003 to 0.3 cd.s/m²). Fast dynamics of rod sensitivity was assessed by a paired-flash paradigm (100 to 4000 ms apart). Additionally, the recovery of b-wave amplitude after exposure to bleaching light (400 cd/m² for 30 s) was evaluated for 70 min with a double flash every 2 minute (0.003 and 10 cd.s/m²; ISI= 1 sec.). Subsequently, photopic ERGs were recorded after 10 min of light adaptation.

Results: : No effects were found either on fully dark-adapted sensitivity or on fast recovery after rod desensitization. In contrast, drug treatment markedly delayed rod recovery from 60 min after bleaching on: at 20 mg/kg b-wave amplitude was 53.9 % lower compared to baseline (p<0.05); and at 5 mg/kg it was 22.2 % lower (p<0.05). Recovery rates were normal 8 weeks after treatment. Light adapted ERG amplitudes showed no changes.

Conclusions: : Treatment with AG-787-14-1 resulted in specific and reversible delay in the recovery of dark adaptation after bleaching in rats. This compound may have therapeutic implications for some forms of retinal and macular degeneration associated with accumulation of biosynthetic intermediates of the visual cycle.

Keywords: retinal degenerations: cell biology • electroretinography: non-clinical • retinal pigment epithelium 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×